First Human Encapsulated Islet Cells Transplanted

Clinical Trial called “first step” in evaluating new therapy

Dr. Soon-Shiong.

Jun 1, 1993

Los Angeles, CA, May 13, 1993 - The first encapsulated pancreatic islet cell transplant in humans was reported today by physician scientists of the National Institute of Transplantation at St. Vincent Medical Center, Los Angeles.

"This clinical trial in humans is the first step in evaluating the potential of encapsulated islets as a new therapy for treating the estimated 1.4 million insulin dependent diabetics in the US," said Patrick Soon-Shiong, MD. "Although the transplant of encapsulated pancreatic cells has successfully reversed diabetes in animal research studies, we have much to learn about the application of this technique in humans."

The transplant recipient is Steven Craig, 38, of Lake Isabella, CA. Craig, who has suffered from insulin-dependent diabetes for over 30 years, underwent minimally-invasive surgery to receive the encapsulated islet cells on Thursday morning, May 6. During the transplant, a solution containing 680,000 encapsulated islet cells from donated cadaveric pancreata was placed free-floating into his peritoneum, or abdominal cavity. The cells are encapsulated in a thin microfilm bubble of alginate extracted from seaweed.

"It is premature to state when this procedure could be considered a clinical treatment," Dr. Soon-Shiong said. "Only when we have fully evaluated the results will we know the true potential of the therapy." Patients selected for Dr. Soon-Shiong's continuing investigations will be those who demonstrate end-stage kidney disease and have had a kidney transplant.

In his animal research studies, Dr. Soon-Shiong reported long-term islet function in five dog recipients of encapsulated islets. Graft survival ranges from 228 to 641 days in four dogs receiving multiple transplants, and for as long as 726 days in the fifth recipient which received a single transplant.

"Despite insulin therapy, major life-threatening and debilitating complications of diabetes still persist," Dr. Soon-Shiong stressed. "Our first recipient, Steven Craig, has suffered from eye problems as well as nerve damage in his lower extremities and kidney failure. The challenge we as physicians face is to intervene before these secondary complications take their toll. Encapsulated islet cells may be a step in that direction."

Click Here To View Or Post Comments

Categories: Diabetes, Insulin, Islet & Pancreas Transplant


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jun 1, 1993

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.